Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.

Mon, 06 Feb 2012 15:13:59 -0800

Pfizer, Ranbaxy Sued Over Alleged Anti-Competitive Scheme for Lipitor Drug
Pfizer Inc. and Ranbaxy Laboratories Ltd. were sued in an antitrust case filed in federal court in New York alleging the drugmakers engaged in an anti-competitive scheme to delay a generic version of Lipitor into the market.

Wed, 25 Jan 2012 19:22:54 -0800

Adulterated Drugs Found in U.S. Probe of Ranbaxy Manufacturing Violations
Ranbaxy Laboratories Ltd. (RBXY) made “adulterated, potentially unsafe” medicines that were illegal to sell, U.S. prosecutors said in a proposed settlement with the Indian drugmaker.

Wed, 25 Jan 2012 15:36:00 -0800

Ranbaxy Announces Court Filing of Consent Decree with U.S. Food and Drug Administration
Ranbaxy Laboratories Ltd. today announced that the consent decree with the U.S. Food and Drug Administration that was signed on December 20, 2011 has been filed with the United States District Court for the District of Maryland.

Wed, 25 Jan 2012 16:39:37 -0800

U.S. settles with drugmaker Ranbaxy over violations
WASHINGTON (Reuters) - Generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) agreed to make broad changes at its plants in the United States and India as part of a long-running U.S. government probe, the ...

Thu, 26 Jan 2012 18:52:32 -0800

Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover
Ranbaxy Laboratories Ltd. (RBXY) , India ’s biggest drugmaker, slumped the most in ten months in Mumbai trading because of costs of a proposed settlement with U.S. authorities over manufacturing violations.

Thu, 26 Jan 2012 23:53:18 -0800

Ranbaxy May Forgo Over $200 Million in Lost Sales, Kotak Says
Ranbaxy Laboratories Ltd., India’s biggest drugmaker, may forego at least $200 million in sales as a result of a proposed settlement with U.S. authorities over manufacturing violations, a Kotak Securities Ltd. analyst said.

Sun, 29 Jan 2012 09:11:12 -0800

Ranbaxy Falls Most Since March on Settlement Costs: Mumbai Mover
Ranbaxy Laboratories Ltd., India’s biggest drugmaker, slumped the most in ten months in Mumbai trading because of costs of a proposed settlement with U.S. authorities over manufacturing violations.

Tue, 07 Feb 2012 16:48:57 GMT

Pfizer, Ranbaxy Sued Over Alleged Anti-Competitive Scheme
BusinessWeek
6 (Bloomberg) -- Pfizer Inc. and Ranbaxy Laboratories Ltd. were sued in an antitrust case filed in federal court in New York alleging the drugmakers engaged in an anti-competitive scheme to delay a generic version of Lipitor into the market.

and more »

Thu, 26 Jan 2012 06:29:30 GMT

Bloomberg

Ranbaxy Reaches Agreement With U.S. Over Alleged Violations at Drug Plants
Bloomberg
Enlarge image Ranbaxy Laboratories Ltd. Arun Sawhney Ranbaxy Laboratories Ltd. Arun Sawhney Prashanth Vishwanathan/Bloomberg Arun Sawhney, managing director of Ranbaxy Laboratories Ltd. Ranbaxy Laboratories Ltd. (RBXY) made “adulterated, ...
Ranbaxy Falls Most Since March on Settlement Costs: Mumbai MoverBusinessWeek
US DOJ Confirms Ranbaxy AgreementWall Street Journal
Ranbaxy stock tanks on court filing in USLivemint
Reuters India -MarketWatch (press release)
all 154 news articles »

Tue, 07 Feb 2012 14:27:56 GMT

Mortgage Accord, JPMorgan, BofA, Dresdner in Court News
BusinessWeek
Pfizer Inc. and Ranbaxy Laboratories Ltd. were sued in an antitrust case filed in federal court in New York alleging the drugmakers engaged in an anti-competitive scheme to delay a generic version of Lipitor into the market. The AFL-AGC Building Trades ...
JPMorgan, Smith & Nephew, Dresdner, GE Capital, Fidelity in Court NewsBloomberg

all 3 news articles »

Tue, 07 Feb 2012 06:12:40 GMT

Daiichi Sankyo in Acquisition Talks With Indian Drug Makers – Report
Wall Street Journal (blog)
Ltd. has started acquisition talks with at least three mid-sized pharmaceutical companies in India, the Economic Times reported Tuesday, citing sources it didn't name. The target companies' products include treatments for diabetes, rheumatology and ...

and more »

Sun, 29 Jan 2012 09:20:56 GMT

FRANCE 24

Ranbaxy's recurring FDA nightmare
Livemint
Investors in Ranbaxy Laboratories Ltd had all but filed away the company's regulatory issues as a bad memory, when its consent decree has forced a rethink. Ranbaxy announced the signing of the decree (without giving details) in December, ...
Department of Justice files consent decree of permanent injunction against RanbaxyIEWY News

all 18 news articles »

Tue, 31 Jan 2012 19:01:15 GMT

Wall Street Journal

Daiichi Sankyo's Outlook Clouded by Legal Costs, Yen
Wall Street Journal
The Japanese company acquired a little more than 60% of Indian generic-drug maker Ranbaxy Laboratories Ltd. for $4.6 billion in 2008. But US government allegations of improper manufacturing practices and data falsification have prevented the company ...

and more »

Fri, 13 Jan 2012 15:40:59 GMT

7Online.com

Sales of Lipitor drop after arrival of generics
7Online.com
By the last week of December, atorvastatin pills from Ranbaxy Laboratories Ltd. and the authorized generic from Watson Pharmaceuticals Inc. - manufactured by Pfizer and marketed by Watson - only picked up another 4 percent between them.

and more »

Directory | Disclaimer

Developed by WorldITLab.

Content by Stock Market Guide